FDA Approves First-in-Class Bayer Drug for Reducing the Risk of Stroke
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of the once-daily pill covers secondary stroke prevention in adults.